Safety Profile of a Virus-Like Particle-Based Vaccine Targeting Self-Protein Interleukin-5 in Horses.

safety self-protein therapeutic vaccine

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
09 May 2020
Historique:
received: 10 04 2020
revised: 05 05 2020
accepted: 05 05 2020
entrez: 14 5 2020
pubmed: 14 5 2020
medline: 14 5 2020
Statut: epublish

Résumé

Identifiants

pubmed: 32397549
pii: vaccines8020213
doi: 10.3390/vaccines8020213
pmc: PMC7349629
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Kommission für Technologie und Innovation
ID : 25758.1 PFLS-LS
Organisme : Evax AG
ID : n.a.

Déclaration de conflit d'intérêts

V.F., K.B, F.T., M.F.B., T.M.K., and A.F.G. are involved in the development of active immunotherapies. The authors S.J., F.O., S.C.T., J.M., T.R., B.W., and E.M. have no conflicts of interest to disclose.

Références

J Exp Med. 1995 Oct 1;182(4):1169-74
pubmed: 7561691
Vet Microbiol. 2009 Jun 12;137(3-4):363-8
pubmed: 19217222
Vet Res. 2006 Nov-Dec;37(6):813-25
pubmed: 16973120
Nat Rev Immunol. 2014 Jun;14(6):377-91
pubmed: 24830344
Toxicol Pathol. 2014 Jun;42(4):725-64
pubmed: 24705884
Proc Natl Acad Sci U S A. 1989 Oct;86(20):8039-43
pubmed: 2682636
J Exp Med. 1924 Apr 30;39(5):631-7
pubmed: 19868873
Vet Immunol Immunopathol. 2013 Jun 15;153(3-4):187-93
pubmed: 23541920
Parasite Immunol. 2014 Nov;36(11):560-72
pubmed: 25180696
Allergy. 2019 Mar;74(3):572-582
pubmed: 30402930
Expert Rev Vaccines. 2018 Sep;17(9):833-849
pubmed: 30173619
Am J Kidney Dis. 1991 Mar;17(3):352-61
pubmed: 1825448
Vaccine. 2010 Jul 19;28(32):5203-11
pubmed: 20538091
Allergy Asthma Immunol Res. 2010 Apr;2(2):87-101
pubmed: 20358022
Expert Rev Vaccines. 2007 Jun;6(3):381-90
pubmed: 17542753
Immunity. 1996 Jan;4(1):15-24
pubmed: 8574848
Vet J. 2008 Sep;177(3):334-44
pubmed: 18023376
J Allergy Clin Immunol. 2018 Oct;142(4):1194-1205.e3
pubmed: 29627082
Mol Ther Methods Clin Dev. 2014 Oct 22;1:14048
pubmed: 26015986
Int Immunol. 2000 Sep;12(9):1275-84
pubmed: 10967022
Dev Comp Immunol. 2006;30(1-2):155-64
pubmed: 16046236
Int Arch Allergy Immunol. 2007;144(4):325-37
pubmed: 17671392
Vet Immunol Immunopathol. 2015 Jul 15;166(1-2):8-21
pubmed: 26004943
Methods. 2006 Sep;40(1):60-5
pubmed: 16997714
J Clin Invest. 2001 Aug;108(3):415-23
pubmed: 11489935
Nature. 1989 Feb 9;337(6207):562-6
pubmed: 2783762
J Exp Med. 1993 Apr 1;177(4):1009-20
pubmed: 8459201
Front Immunol. 2017 Aug 25;8:1044
pubmed: 28890720
J Exp Med. 1931 Jul 31;54(3):431-6
pubmed: 19869929
Vet Immunol Immunopathol. 2012 Jul 15;148(1-2):139-44
pubmed: 21700344
Expert Rev Vaccines. 2010 Oct;9(10):1149-76
pubmed: 20923267
J Exp Med. 1929 Sep 30;50(4):533-50
pubmed: 19869645
Nature. 1994 Nov 3;372(6501):100-3
pubmed: 7969401
Am J Pathol. 1991 Oct;139(4):855-67
pubmed: 1928303
NPJ Vaccines. 2017 Oct 23;2:30
pubmed: 29263885
Eur J Immunol. 1994 Dec;24(12):2966-73
pubmed: 7805723
Exp Hematol. 1992 Feb;20(2):229-34
pubmed: 1544392
Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13263-8
pubmed: 11069289
Proc Natl Acad Sci U S A. 2015 Feb 17;112(7):2000-5
pubmed: 25646460
Vaccine. 2010 Apr 19;28(18):3192-200
pubmed: 20189490

Auteurs

Sigridur Jonsdottir (S)

Clinical Immunology Group, Department for Clinical Research VPH, Vetsuisse Faculty of the University of Bern, Länggassstrasse 124, 3012 Bern, Switzerland.
Department of Dermatology, University Hospital Zurich, Wagistrasse 12, 8952 Schlieren, Switzerland.
Faculty of Medicine University of Zurich, 8091 Zurich, Switzerland.

Victoria Fettelschoss (V)

Department of Dermatology, University Hospital Zurich, Wagistrasse 12, 8952 Schlieren, Switzerland.
Faculty of Medicine University of Zurich, 8091 Zurich, Switzerland.
Evax AG, Hörnlistrass 3, 9542 Münchwilen, Switzerland.

Florian Olomski (F)

Department of Dermatology, University Hospital Zurich, Wagistrasse 12, 8952 Schlieren, Switzerland.
Faculty of Medicine University of Zurich, 8091 Zurich, Switzerland.

Stephanie C Talker (SC)

Institute of Virology and Immunology, Länggassstrasse 122, 3012 Bern, Switzerland.
Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Länggassstrasse 122, 3012 Bern, Switzerland.

Jelena Mirkovitch (J)

Clinical Immunology Group, Department for Clinical Research VPH, Vetsuisse Faculty of the University of Bern, Länggassstrasse 124, 3012 Bern, Switzerland.

Tanya Rhiner (T)

Department of Dermatology, University Hospital Zurich, Wagistrasse 12, 8952 Schlieren, Switzerland.
Faculty of Medicine University of Zurich, 8091 Zurich, Switzerland.

Katharina Birkmann (K)

Evax AG, Hörnlistrass 3, 9542 Münchwilen, Switzerland.

Franziska Thoms (F)

Department of Dermatology, University Hospital Zurich, Wagistrasse 12, 8952 Schlieren, Switzerland.
Faculty of Medicine University of Zurich, 8091 Zurich, Switzerland.

Bettina Wagner (B)

Departments of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, 14853-0001 NY, USA.

Martin F Bachmann (MF)

RIA Immunology, Inselspital, University of Bern, 3012 Bern, Switzerland.
Jenner Institute, Nuffield Department of Medicine, Henry Welcome Building for Molecular Physiology, University of Oxford, OX1 2JD Oxford, UK.

Thomas M Kündig (TM)

Department of Dermatology, University Hospital Zurich, Gloriastrasse 31, 8091 Zurich, Switzerland.

Eliane Marti (E)

Clinical Immunology Group, Department for Clinical Research VPH, Vetsuisse Faculty of the University of Bern, Länggassstrasse 124, 3012 Bern, Switzerland.

Antonia Fettelschoss-Gabriel (A)

Department of Dermatology, University Hospital Zurich, Wagistrasse 12, 8952 Schlieren, Switzerland.
Faculty of Medicine University of Zurich, 8091 Zurich, Switzerland.
Evax AG, Hörnlistrass 3, 9542 Münchwilen, Switzerland.

Classifications MeSH